Australia Markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
54.42+0.45 (+0.83%)
At close: 04:00PM EDT
54.23 -0.19 (-0.35%)
After hours: 06:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 358.10
52-week low 336.91
50-day moving average 348.58
200-day moving average 345.96

Share statistics

Avg vol (3-month) 32.02M
Avg vol (10-day) 32.22M
Shares outstanding 52.51B
Implied shares outstanding 6N/A
Float 82.22B
% held by insiders 10.01%
% held by institutions 110.34%
Shares short (12 Jan 2023) 42.96M
Short ratio (12 Jan 2023) 41.33
Short % of float (12 Jan 2023) 4N/A
Short % of shares outstanding (12 Jan 2023) 40.12%
Shares short (prior month 14 Dec 2022) 42.84M

Dividends & splits

Forward annual dividend rate 41.75
Forward annual dividend yield 43.72%
Trailing annual dividend rate 33.20
Trailing annual dividend yield 35.93%
5-year average dividend yield 43.86
Payout ratio 461.72%
Dividend date 322 June 2023
Ex-dividend date 425 May 2022
Last split factor 25:1
Last split date 329 Sept 2013

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 14.81%
Operating margin (ttm)26.18%

Management effectiveness

Return on assets (ttm)6.07%
Return on equity (ttm)9.59%

Income statement

Revenue (ttm)45.39B
Revenue per share (ttm)18.13
Quarterly revenue growth (yoy)10.00%
Gross profit (ttm)31.69B
EBITDA 14.57B
Net income avi to common (ttm)6.72B
Diluted EPS (ttm)5.84
Quarterly earnings growth (yoy)29.20%

Balance sheet

Total cash (mrq)12.74B
Total cash per share (mrq)5.08
Total debt (mrq)21.21B
Total debt/equity (mrq)28.85
Current ratio (mrq)1.42
Book value per share (mrq)25.19

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A